Clinical Trial Update: Mesh Ablator Versus Cryoballoon Pulmonary Vein Ablation of Symptomatic Paroxysmal Atrial Fibrillation [Phase 4]

View source ↗

Summary

A phase 4 trial comparing Mesh Ablator versus Cryoballoon ablation for symptomatic paroxysmal atrial fibrillation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Cryoballoon
• Mesh Ablator

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Symptomatic Paroxysmal Atrial Fibrillation | Phase 4 | Status: TERMINATED